[Feedback on the first three years of application of the reform of the third cycle in oncology].

La phase socle en oncologie : retour d’expérience sur les trois premières années d’application de la réforme du troisième cycle.

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 07 01 2022
revised: 18 01 2022
accepted: 19 01 2022
pubmed: 9 2 2022
medline: 3 3 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

Since the establishment of the reform of medical studies' third cycle in 2017, the first two residency semesters define the "phase socle" whose objective is to provide the basic knowledge of the specialty. We have carried out a declarative survey, submitted in 2020 to all French residents in Oncology whose "phase socle" had taken place during the first 3 years of the reform. The main objectives of this survey were to evaluate the theoretical teaching of oncology as well as the practical hospital training provided during this phase. The response rate was 44% (among 355 residents, 155 answered). In terms of theoretical training, the level of satisfaction with the national teaching courses of the Collège National des Enseignants en Cancérologie and the distant learning courses on the SIDES-NG platform was considered satisfactory (average visual analog scale of 6.7/10 and 5.7/10, respectively). There was greater heterogeneity in the organization of local courses, of which only 50% of base phase residents benefited. In terms of practical training, the training value of the medical oncology and radiation oncology residencies was good (visual analogue scale 7.9/10 and 6.7/10, respectively), with educational objectives adapted to the base phase, but with a greater workload for medical oncology. This study provides feedback that shows the success of this reform in oncology. It also offers suggestions, which could be the basis to improve the formation of oncology residents.

Identifiants

pubmed: 35131091
pii: S0007-4551(22)00039-X
doi: 10.1016/j.bulcan.2022.01.007
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

130-138

Informations de copyright

Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Pierre-Yves Cren (PY)

Centre Oscar-Lambret, département d'oncologie médicale, 59000 Lille, France; Université de Lille, 59000 Lille, France.

Julie Chartier (J)

Hôpital Cochin, département d'oncologie médicale, 75014 Paris, France; Association pour l'enseignement et la recherche des internes en oncologie, 75014 Paris, France.

Nicolas Penel (N)

Centre Oscar-Lambret, département d'oncologie médicale, 59000 Lille, France; Université de Lille, 59000 Lille, France.

Florence Huguet (F)

Institut universitaire de cancérologie, AP-HP, hôpital Tenon, Sorbonne université, service d'oncologie radiothérapie, 75020 Paris, France; Collège national des enseignants en cancérologie, 75006 Paris, France.

Jean-Philippe Spano (JP)

Collège national des enseignants en cancérologie, 75006 Paris, France; Institut Pierre Louis d'épidémiologie et de Santé Publique, AP-HP, hôpitaux universitaires Pitié Salpêtrière - Charles-Foix, oncologie médicale, Sorbonne université, Inserm, équipe Theravir, 75013 Paris, France.

Luc Ollivier (L)

Société Française des jeunes radiothérapeutes oncologues, 47, rue de la Colonie, 75013 Paris, France; Institut de cancérologie de l'Ouest, site de Nantes, 44, boulevard Jacques-Monod, 44800 Saint-Herblain, France.

Matthieu Delaye (M)

Association pour l'enseignement et la recherche des internes en oncologie, 75014 Paris, France; Institut Curie, département d'oncologie médicale, 92210 Saint-Cloud, France.

Anthony Turpin (A)

Université de Lille, 59000 Lille, France; CHU de Lille, département d'oncologie médicale, 59000 Lille, France. Electronic address: anthony.turpin@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH